Picture of Xvivo Perfusion AB logo

XVIVO — Xvivo Perfusion AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareSpeculativeMid CapFalling Star

Brief: Xvivo Gets Market Approval From FDA For Steen Solution And XPS

April 29 (Reuters) - Xvivo Perfusion AB  XVIVO.ST :
    * XVIVO HAS RECEIVED MARKET APPROVAL (PMA) FROM THE FDA FOR
STEEN
SOLUTION™ AND XPS™
    * ON APRIL 26, 2019 XVIVO RECEIVED PREMARKET APPROVAL (PMA)
FROM
FDA FOR PRODUCTS XPS™ AND STEEN SOLUTION™ FOR SALE ON AMERICAN
MARKET

Source text for Eikon:  ID:nWkrzFr4C 
Further company coverage:  XVIVO.ST 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))

Recent news on Xvivo Perfusion AB

See all news